Dihydrotachysterol (DHT) and supplemental calcium therapy in dialysis patients
Kliger, A.S.; Yap, P.; Jensen, P.; Finkelstein, F.O.
Proceedings of the Clinical Dialysis and Transplant Forum 6: 184-190
1976
ISSN/ISBN: 0094-6044 PMID: 1029884 Document Number: 104369
Document emailed within 1 workday
Related Documents
Ahmed, K.Y.; Varghese, Z.; Wills, M.R.; Meinhard, E.; Skinner, R.K.; Baillod, R.A.; Moorhead, J.F. 1976: Persistent hypophosphataemia and osteomalacia in dialysis patients not on oral phosphate-binders: Response to dihydrotachysterol therapy Lancet 2(7983): 439-442Pagliari, B.; Baretta, A.; De Cristofaro, V.; Samà, F.; Cantaluppi, A.; Martis, L.; Imbasciati, E. 1991: Short-term effects of low-calcium dialysis solutions on calcium mass transfer, ionized calcium, and parathyroid hormone in CAPD patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 11(4): 326-329
Hutchison, A.J.; Merchant, M.; Boulton, H.F.; Hinchcliffe, R.; Gokal, R. 1993: Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25 mmol/L calcium, 0.25 mmol/L magnesium dialysis fluid Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 13(3): 219-223
De Cristofaro, V.; Samà, F.; Pagliari, B.; Colturi, C.; Sidoti, A.; Masa, A.; Filippini, M.; Comelli, M.; Pedrini, L. 1998: Calcium-PTH relationship in dialysis patients: the pitfalls of using a constant dialysate calcium concentration during the dynamic tests Clinical Nephrology 49(2): 113-120
Hardy-Yverneau, P.; Shenouda, M.; Moriniere, P.; Legallais, C.; Brazier, M.; Achard, J.; Fournier, A. 1998: The dependency of calcium set point on basal plasma calcium in dialysis patients: a better explanation for the discrepancies regarding its link with PTH secretion than methodological differences Clinical Nephrology 50(4): 236-246
Chertow, G.M.; Dillon, M.; Burke, S.K.; Steg, M.; Bleyer, A.J.; Garrett, B.N.; Domoto, D.T.; Wilkes, B.M.; Wombolt, D.G.; Slatopolsky, E. 1999: A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients Clinical Nephrology 51(1): 18-26
Khilnani, G.C.; Bhatta, N. 2002: Air travel and supplemental oxygen therapy in patients with cardiopulmonary diseases Journal of the Association of Physicians of India 50: 811-815
Kushihata, S.; Yorioka, N. 1998: Effect of H2-blockers on serum calcium and phosphorus in hemodialysis patients on calcium carbonate therapy Clinical Nephrology 50(3): 198-199
Kies, C.; Harms, J.M. 1989: Copper absorption as affected by supplemental calcium, magnesium, manganese, selenium and potassium Advances in Experimental Medicine and Biology 258: 45-58
Diskin, C.J.; Stokes, T.J.; Dansby, L.M.; Radcliff, L.; Carter, T.B. 2010: Can omeprazole reduce the incidence of hypercalcemia in dialysis patients using calcium containing phosphate binders? Journal of Nephrology 23(4): 438-443
Borrego, J.; Pérez del Barrio, P.; Serrano, P.; García Cortés, M.J.; Sánchez Perales, M.C.; Borrego, F.J.; Liébana, A.; Gil Cunquero, J.M.; Pérez Bañasco, V. 2000: A comparison of phosphorus-chelating effect of calcium carbonate versus calcium acetate before dialysis Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 20(4): 348-354
Pancioli, A.M.; Bullard, M.J.; Grulee, M.E.; Jauch, E.C.; Perkis, D.F. 2002: Supplemental oxygen use in ischemic stroke patients: does utilization correspond to need for oxygen therapy? Archives of Internal Medicine 162(1): 49-52
Ramos, J.M.; Muirhead, N.; Laker, M.F.; Ward, M.K.; Kerr, D.N. 1983: Blood phosphate and calcium metabolism in bicarbonate dialysis of chronic stable hemodialysis patients Nephrologie 4(4-5): 231-235
Rotellar, C.; Kinsel, V.; Goggins, M.; Tarman, G.; Stull, M.; Mazzoni, M.J.; Mosher, W.F.; Rakowski, T.A.; Winchester, J.F. 1993: Does low-calcium dialysate accelerate secondary hyperparathyroidism in continuous ambulatory peritoneal dialysis patients? Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 13(Suppl 2): S471-S472
Zwiech, R.ł; Dryja, P.ła.; Łacina, D.; Króliczak, V.; Chrul, S.ła.; Kacprzyk, F. 2011: The influence of short-term magnesium carbonate treatment on calcium-phosphorus balance in dialysis patients Wiadomosci Lekarskie 64(1): 9-14
Thode, J.; Boyd, J.C.; Ladenson, J.H. 1987: Activity measurements of calcium, sodium, potassium, and chloride after equilibrium dialysis used to show lack of evidence for protein interference with calcium electrodes Clinical Chemistry 33(10): 1811-1813
Emel Şahin; Ayşe Yeşim Göçmen; Saadet Gümüşlü; Sahin, M.; Hüseyin Koçak; Tuncer, M. 2011: Lipid Peroxidation and Parathyroid Hormone Influence the Cytosolic Calcium Levels of Erythrocytes in Peritoneal Dialysis Patients Clinical Laboratory 57(7-8): 551-557
Suzuki, H.; Inoue, T.; Kobayashi, K.; Shoda, J.; Nakamoto, H. 2006: The newly developed calcium antagonist, azelnidipine, increases drain volume in continuous ambulatory peritoneal dialysis patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 22: 18-23
Suda, A.; Ota, K.; Shirasu, H. 1974: Dihydrotachysterol in the treatment of bone abnormality in patients with renal failure undergoing chronic hemodialysis Calcified Tissue Research 15(2): 159-160
Hutchison, A.J.; Gokal, R. 1992: Towards tailored dialysis fluids in CAPD--the role of reduced calcium and magnesium in dialysis fluids Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 12(2): 199-203